Baird’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
$977K Sell
14,933
-1,374
-8% -$91.4K 0.01% 757
2014
Q4
$1.06M Sell
16,307
-2,890
-15% -$186K 0.01% 720
2014
Q3
$1.15M Buy
19,197
+1,174
+7% +$76.7K 0.02% 620
2014
Q2
$1.25M Buy
18,023
+739
+4% +$47.9K 0.02% 610
2014
Q1
$1.13M Sell
17,284
-2,305
-12% -$150K 0.02% 605
2013
Q4
$1.21M Buy
19,589
+138
+0.7% +$7.99K 0.02% 566
2013
Q3
$1.04M Sell
19,451
-239
-1% -$12.3K 0.02% 581
2013
Q2
$898K Buy
+19,690
New +$853K 0.02% 601

Other funds holding STJ

Baird's STJ Position: Q1 2015 in Review

Baird reduced its St Jude Medical (STJ) stake by 8.4% in Q1 2015, selling an estimated $91.4K and leaving 14,933 shares worth $977K. The position accounts for 0.01% of the portfolio, ranked #757.

Baird first reported a position in STJ in Q2 2013 and has held it in 8 quarters since. The position peaked at $1.25M in Q2 2014. 590 funds tracked by Wall St. Rank hold STJ as of Q1 2015.

  • Baird held 14,933 shares of St Jude Medical worth $977K as of Q1 2015.
  • Baird sold 1,374 St Jude Medical shares in Q1 2015, an estimated $91.4K.
  • St Jude Medical made up 0.01% of Baird's portfolio in Q1 2015, its #757 holding.
  • Baird first reported a position in St Jude Medical in Q2 2013 and has held it in 8 quarters since.
  • Baird's St Jude Medical position peaked at $1.25M in Q2 2014.
  • 590 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2015.

Based on Baird's 13F filing for Q1 2015, filed 13 May 2015.